National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute on Alcohol Abuse and Alcoholism (NIAAA) sits in the top decile of US sponsors by registered trial count (#253 of 15,742 sponsors by registered trial count).
National Institute on Alcohol Abuse and Alcoholism (NIAAA): 93 sponsored US clinical trials, 16 recruiting.
National Institute on Alcohol Abuse and Alcoholism (NIAAA) sponsors 93 registered US clinical trials on ClinicalTrials.gov, 16 of them currently recruiting, and 71 completed. 9 of these trials are in Phase 3-4 (later-stage) and 58 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcoholism, with 11 trials.
Top-decile sponsor footprint
National Institute on Alcohol Abuse and Alcoholism (NIAAA) ranks in the top decile of sponsors by registered trial count (#253 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
71 of 77 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
93 total, page 2 of 2
Computer-Assisted Self-Administration of Ethanol
NCT00713492
The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion
NCT00667771
Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics
NCT00605904
Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
NCT00498628
Aripiprazole and Topiramate on Free-Choice Alcohol Use
NCT00884884
OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine
NCT00401999
Stepped Care for Mandated College Students
NCT00247182
Psychoeducation for Hepatitis and Alcohol Behaviors
NCT00598416
Medication and Counseling for Controlled Drinking (Project SMART)
NCT00444418
Effect of LY686017 on Alcohol Craving
NCT00310427
Individualized Treatment Program for Alcohol Problems
NCT00298792
Treatment of Patients With Alcoholism and Attention Deficit Disorder
NCT00261872
Aftercare for Adolescents Treated for Alcohol Abuse and Dependence
NCT00561041
Alcoholism Assessment and Treatment
NCT00106093
Rimonabant to Reduce Alcohol Consumption
NCT00075205
PET Imaging of DHA Metabolism
NCT00074503
The Effect of Ethanol on Brain Activity
NCT00074360
Influence of Age and Sex on Alcohol Metabolism and Acute Responses
NCT00070577
Hangover, Congeners, Sleep and Occupational Performance
NCT00247585
Healthy Living as You Age
NCT00379093
Blood Sample Donations to Study the Role of Genes in Pain
NCT00341367
A Placebo-Controlled Trial of Memantine for Alcohol Dependence
NCT00246415
Role of Dopamine in Response to Alcohol
NCT00050219
Brain Function in Response to Motivational Stimuli
NCT00047866
Bupropion as a Smoking Cessation Aid in Alcoholics
NCT00044434
Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)
NCT00027079
Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam
NCT00229125
Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress
NCT00014027
Effect of Fluoxetine (Prozac) on Domestic Violence
NCT00011765
Serotonin in Alcoholism
NCT00011752
Drug Treatment for Alcoholics With Bipolar Disorder
NCT00000439
Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)
NCT00006204
The Effect of Positive and Negative Emotions on Brain Activity in Alcoholics and Nonalcoholics
NCT00001675
Screening Evaluation for Studies of the National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NCT00001673
Ondansetron Treatment for Alcoholism
NCT00000443
Sertraline and Cognitive Therapy in Depressed Alcoholics
NCT00000458
Drug Therapy for Alcohol Detoxification
NCT00000441
Sertraline and Naltrexone for Alcohol Dependence
NCT00000440
Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
NCT00000446
Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal
NCT00011297
Naltrexone Treatment of Alcohol Dependence
NCT00000452
Behavior and Naltrexone Treatment for Alcoholics
NCT00000449
Use of Naltrexone in a Clinical Setting
NCT00000445
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 21 |
| Phase 2 | 37 |
| Phase 3 | 1 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the National Institute on Alcohol Abuse and Alcoholism (NIAAA) pipeline
16 recruiting of 93 indexed (17% open); 71 completed (76%).
Phase mix: 9 late (III/IV) vs 58 early (I/II) (early-phase heavy).
Top condition: Alcoholism (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute on Alcohol Abuse and Alcoholism (NIAAA): open-pipeline peers nationwide
Peers matched on 93 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
National Institute on Alcohol Abuse and Alcoholism (NIAAA) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 93 trials (± recruiting share)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 93 trials · 13% recruiting
- Roxane Laboratories · 93 trials · 0% recruiting
- Colorado State University · 94 trials · 21% recruiting
- Endeavor Health · 94 trials · 20% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Emory University · 17% recruiting · 1,208 trials
- Baylor Research Institute · 17% recruiting · 180 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this National Institute on Alcohol Abuse and Alcoholism (NIAAA) page
93 registered trials is a research-attention snapshot, not an endorsement of National Institute on Alcohol Abuse and Alcoholism (NIAAA) or any single study.
- 16 of National Institute on Alcohol Abuse and Alcoholism (NIAAA)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alcoholism is the condition National Institute on Alcohol Abuse and Alcoholism (NIAAA) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcoholism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
National Institute on Alcohol Abuse and Alcoholism (NIAAA) pipeline card: 93 registered trials from official public datasets.Report a data error.